The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Insomnia Therapeutics Drugs market was valued at US$ 2921.6 million in 2023 and is anticipated to reach US$ 3710.3 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need.
Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Insomnia Therapeutics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insomnia Therapeutics Drugs.
Report Scope
The Insomnia Therapeutics Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030.
This report segments the global Insomnia Therapeutics Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insomnia Therapeutics Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company (Partial List):
- Takeda Pharmaceutical Company Ltd.
- Vanda Pharmaceuticals
- Merck & Co., Inc.
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Sumitomo Dainippon Pharma Co., Ltd
- Sanofi
- Paratek Pharmaceuticals Inc.
- Ebb Therapeutics
Segment by Type
- Benzodiazepines
- Nonbenzodiazepines
- Antidepressants
- Orexin Antagonists
- Melatonin Antagonists
- Others
Segment by Application
- Prescription
- Over-the-Counter (OTC)
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Insomnia Therapeutics Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Insomnia Therapeutics Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Benzodiazepines
1.2.3 Nonbenzodiazepines
1.2.4 Antidepressants
1.2.5 Orexin Antagonists
1.2.6 Melatonin Antagonists
1.2.7 Others
1.3 Market by Application
1.3.1 Global Insomnia Therapeutics Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Prescription
1.3.3 Over-the-Counter (OTC)
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Insomnia Therapeutics Drugs Market Perspective (2019-2030)
2.2 Insomnia Therapeutics Drugs Growth Trends by Region
2.2.1 Global Insomnia Therapeutics Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Insomnia Therapeutics Drugs Historic Market Size by Region (2019-2024)
2.2.3 Insomnia Therapeutics Drugs Forecasted Market Size by Region (2025-2030)
2.3 Insomnia Therapeutics Drugs Market Dynamics
2.3.1 Insomnia Therapeutics Drugs Industry Trends
2.3.2 Insomnia Therapeutics Drugs Market Drivers
2.3.3 Insomnia Therapeutics Drugs Market Challenges
2.3.4 Insomnia Therapeutics Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Insomnia Therapeutics Drugs Players by Revenue
3.1.1 Global Top Insomnia Therapeutics Drugs Players by Revenue (2019-2024)
3.1.2 Global Insomnia Therapeutics Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Insomnia Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Insomnia Therapeutics Drugs Revenue
3.4 Global Insomnia Therapeutics Drugs Market Concentration Ratio
3.4.1 Global Insomnia Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Insomnia Therapeutics Drugs Revenue in 2023
3.5 Insomnia Therapeutics Drugs Key Players Head office and Area Served
3.6 Key Players Insomnia Therapeutics Drugs Product Solution and Service
3.7 Date of Enter into Insomnia Therapeutics Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Insomnia Therapeutics Drugs Breakdown Data by Type
4.1 Global Insomnia Therapeutics Drugs Historic Market Size by Type (2019-2024)
4.2 Global Insomnia Therapeutics Drugs Forecasted Market Size by Type (2025-2030)
5 Insomnia Therapeutics Drugs Breakdown Data by Application
5.1 Global Insomnia Therapeutics Drugs Historic Market Size by Application (2019-2024)
5.2 Global Insomnia Therapeutics Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Insomnia Therapeutics Drugs Market Size (2019-2030)
6.2 North America Insomnia Therapeutics Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Insomnia Therapeutics Drugs Market Size by Country (2019-2024)
6.4 North America Insomnia Therapeutics Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Insomnia Therapeutics Drugs Market Size (2019-2030)
7.2 Europe Insomnia Therapeutics Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Insomnia Therapeutics Drugs Market Size by Country (2019-2024)
7.4 Europe Insomnia Therapeutics Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Insomnia Therapeutics Drugs Market Size (2019-2030)
8.2 Asia-Pacific Insomnia Therapeutics Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Insomnia Therapeutics Drugs Market Size (2019-2030)
9.2 Latin America Insomnia Therapeutics Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Insomnia Therapeutics Drugs Market Size by Country (2019-2024)
9.4 Latin America Insomnia Therapeutics Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Insomnia Therapeutics Drugs Market Size (2019-2030)
10.2 Middle East & Africa Insomnia Therapeutics Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda Pharmaceutical Company Ltd.
11.1.1 Takeda Pharmaceutical Company Ltd. Company Detail
11.1.2 Takeda Pharmaceutical Company Ltd. Business Overview
11.1.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Introduction
11.1.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapeutics Drugs Business (2019-2024)
11.1.5 Takeda Pharmaceutical Company Ltd. Recent Development
11.2 Vanda Pharmaceuticals
11.2.1 Vanda Pharmaceuticals Company Detail
11.2.2 Vanda Pharmaceuticals Business Overview
11.2.3 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Introduction
11.2.4 Vanda Pharmaceuticals Revenue in Insomnia Therapeutics Drugs Business (2019-2024)
11.2.5 Vanda Pharmaceuticals Recent Development
11.3 Merck & Co., Inc.
11.3.1 Merck & Co., Inc. Company Detail
11.3.2 Merck & Co., Inc. Business Overview
11.3.3 Merck & Co., Inc. Insomnia Therapeutics Drugs Introduction
11.3.4 Merck & Co., Inc. Revenue in Insomnia Therapeutics Drugs Business (2019-2024)
11.3.5 Merck & Co., Inc. Recent Development
11.4 Pfizer Inc.
11.4.1 Pfizer Inc. Company Detail
11.4.2 Pfizer Inc. Business Overview
11.4.3 Pfizer Inc. Insomnia Therapeutics Drugs Introduction
11.4.4 Pfizer Inc. Revenue in Insomnia Therapeutics Drugs Business (2019-2024)
11.4.5 Pfizer Inc. Recent Development
11.5 Teva Pharmaceutical Industries Ltd.
11.5.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.5.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.5.3 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Introduction
11.5.4 Teva Pharmaceutical Industries Ltd. Revenue in Insomnia Therapeutics Drugs Business (2019-2024)
11.5.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.6 Mylan N.V.
11.6.1 Mylan N.V. Company Detail
11.6.2 Mylan N.V. Business Overview
11.6.3 Mylan N.V. Insomnia Therapeutics Drugs Introduction
11.6.4 Mylan N.V. Revenue in Insomnia Therapeutics Drugs Business (2019-2024)
11.6.5 Mylan N.V. Recent Development
11.7 Sumitomo Dainippon Pharma Co., Ltd
11.7.1 Sumitomo Dainippon Pharma Co., Ltd Company Detail
11.7.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview
11.7.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Introduction
11.7.4 Sumitomo Dainippon Pharma Co., Ltd Revenue in Insomnia Therapeutics Drugs Business (2019-2024)
11.7.5 Sumitomo Dainippon Pharma Co., Ltd Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Detail
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Insomnia Therapeutics Drugs Introduction
11.8.4 Sanofi Revenue in Insomnia Therapeutics Drugs Business (2019-2024)
11.8.5 Sanofi Recent Development
11.9 Paratek Pharmaceuticals Inc.
11.9.1 Paratek Pharmaceuticals Inc. Company Detail
11.9.2 Paratek Pharmaceuticals Inc. Business Overview
11.9.3 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Introduction
11.9.4 Paratek Pharmaceuticals Inc. Revenue in Insomnia Therapeutics Drugs Business (2019-2024)
11.9.5 Paratek Pharmaceuticals Inc. Recent Development
11.10 Ebb Therapeutics
11.10.1 Ebb Therapeutics Company Detail
11.10.2 Ebb Therapeutics Business Overview
11.10.3 Ebb Therapeutics Insomnia Therapeutics Drugs Introduction
11.10.4 Ebb Therapeutics Revenue in Insomnia Therapeutics Drugs Business (2019-2024)
11.10.5 Ebb Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
